Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Poltreg

Poltreg?uq=U5Zpp9ZJ
2015 FOUNDED
PRIVATE STATUS
PE Growth LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Developer of a therapy for the treatment of type 1 diabetes. The company engages in collecting T-regulatory lymphocytes which plays an immunoprotective role against the negative effects and development of the disease as well as combats the causes of the disease, enabling patients in Poland to improve the quality of life.

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • Ul. Trzy Lipy 3
  • Gdańsk, 80-172
  • Poland

Poltreg Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Poltreg‘s full profile, request access.

Request full access to PitchBook

Poltreg Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Poltreg‘s full profile, request access.

Request full access to PitchBook

Poltreg Executive Team (4)

Name Title Board
Seat
Contact
Info
Katarzyna Michalak-Magda Chief Executive Officer & President of the Board
Małgorzata Myśliwiec Co-Founder
Natalia Marek-Trzonkowska Co-Founder
Piotr Trzonkowski Co-Founder

Poltreg Board Members (3)

Name Representing Role Since Contact
Info
000000000 00000000-00000 Poltreg Chief Executive Officer & President of the Board 000 0000
000000 00000000 Poltreg Chairman 000 0000
0000000 000000000 Paan Capital Board Member 000 0000